» Articles » PMID: 10335785

Audio-computer Interviewing to Measure Risk Behaviour for HIV Among Injecting Drug Users: a Quasi-randomised Trial

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1999 May 21
PMID 10335785
Citations 232
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We aimed to assess audio-computer-assisted self-interviewing (audio-CASI) as a method of reducing under-reporting of HIV risk behaviour among injecting drug users.

Methods: Injecting drug users were interviewed at syringe-exchange programmes in four US cities. Potential respondents were randomly selected from participants in the syringe exchanges, with weekly alternate assignment to either traditional face-to-face interviews or audio-CASI. The questionnaire included items on sociodemographic characteristics, drug use, and HIV risk behaviours for 30 days preceding the interview. We calculated odds ratios for the difference in reporting of HIV risk behaviours between interview methods.

Findings: 757 respondents were interviewed face-to-face, and 724 were interviewed by audio-CASI. More respondents reported HIV risk behaviours and other sensitive behaviours in audio-CASI than in face-to-face interviews (odds ratios for reporting of rented or bought used injection equipment in audio-CASI vs face-to-face interview 2.1 [95% CI 1.4-3.3] p=0.001; for injection with borrowed used injection equipment 1.5 [1.1-2.2] p=0.02; for renting or selling used equipment 2.3 [1.3-4.0] p=0.003).

Interpretation: Although validation of these self-reported behaviours was not possible, we propose that audio-CASI enables substantially more complete reporting of HIV risk behaviour. More complete reporting might increase understanding of the dynamics of HIV transmission and make the assessment of HIV-prevention efforts easier.

Citing Articles

Acceptance and feasibility of a low-threshold and substitution services-based periodical monitoring system for blood-borne and sexually transmitted infections among people who inject drugs in Germany: a mixed-methods analysis.

Krings A, Steffen G, Zimmermann R Harm Reduct J. 2024; 21(1):62.

PMID: 38486197 PMC: 10938743. DOI: 10.1186/s12954-024-00977-0.


Population-level prevalence of detectable HIV viremia in people who inject drugs (PWID) in Ukraine: Implications for HIV treatment and case finding interventions.

Sazonova Y, Kulchynska R, Azarskova M, Liulchuk M, Salyuk T, Doan I PLoS One. 2023; 18(10):e0290661.

PMID: 37883454 PMC: 10602286. DOI: 10.1371/journal.pone.0290661.


My Body, My Culture: Understanding Body Image Concerns Among West African Immigrant Women.

Min M, Espinosa A, Akinsulure-Smith A J Immigr Minor Health. 2022; 25(3):634-642.

PMID: 36344860 DOI: 10.1007/s10903-022-01421-w.


Double Impact: A Dyadic Discrimination Model for Poor, Minority, and Pregnant Couples.

Powell A, Kershaw T, Gordon D J Urban Health. 2022; 99(6):1033-1043.

PMID: 36149546 PMC: 9727055. DOI: 10.1007/s11524-022-00682-y.


Optimizing an mHealth Intervention to Improve Uptake and Adherence to HIV Pre-exposure Prophylaxis in Young Transgender Women: Protocol for a Multi-Phase Trial.

MacDonell K, Wang B, Phanuphak N, Janamnuaysook R, Srimanus P, Rongkavilit C JMIR Res Protoc. 2022; 11(5):e37659.

PMID: 35587370 PMC: 9164094. DOI: 10.2196/37659.